Author

David Linfeldt

Lund University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Agatheeswaran SubramaniamiD· 1 shared Anne de Snaijer· 1 shared Fredrik EkiD· 1 shared Jenny HanssoniD· 1 shared Kristijonas ŽemaitisiD· 1 shared Mattias MagnussoniD· 1 shared Rohit SivaprasadiD· 1 shared Sudip GhoshiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Agatheeswaran SubramaniamORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer-associated KBTBD4 mutations induce differentiation defects and confer a unique therapeutic vulnerability

Rohit Sivaprasad, Kristijonas Žemaitis, David Linfeldt, Sudip Ghosh, Anne de Snaijer, Mattias Magnusson, Fredrik Ek, Jenny Hansson, Agatheeswaran Subramaniam

This study models KBTBD4 mutations in hematopoietic stem cells, identifies HDAC inhibitors as therapeutic agents, and reveals their mechanism of action.

Cancer Gene Therapy · Aug 10, 2026Peer-reviewedCancer Biology